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Background: Studies have shown that lifestyle interventions are effective in preventing or delaying the onset of
type 2 diabetes in high-risk patients. However, research on the effectiveness of lifestyle interventions in high-risk
immigrant populations with different cultural and socioeconomic backgrounds is scarce. The aim was to design
a culturally adapted lifestyle intervention for an immigrant population and to evaluate its effectiveness and
cost-effectiveness.
Methods/design: In this randomized controlled trial, 308 participants (born in Iraq, living in Malmö, Sweden
and at high risk of type 2 diabetes) will be allocated to either a culturally adapted intervention or a control
group. The intervention will consist of 10 group counseling sessions focusing on diet, physical activity and
behavioral change over 6 months, and the offer of exercise sessions. Cultural adaptation includes gender-
specific exercise sessions, and counseling by a health coach community member. The control group will receive
the information about healthy lifestyle habits provided by the primary health care center. The primary outcome
is change in fasting glucose level. Secondary outcomes are changes in body mass index, insulin sensitivity,
physical activity, food habits and health-related quality of life. Measurements will be taken at baseline, after 3
and 6 months. Data will be analyzed by the intention-to-treat approach. The cost-effectiveness during the trial
period and over the longer term will be assessed by simulation modeling from patient, health care and
societal perspectives.
Discussion: This study will provide a basis to measure the effectiveness of a lifestyle intervention designed
for immigrants from the Middle East in terms of improvement in glucose metabolism, and will also assess its
cost-effectiveness. Results from this trial may help health care providers and policy makers to adapt and
implement lifestyle interventions suitable for this population group that can be conducted in the community.
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Type 2 diabetes (T2D), impaired fasting glucose (IFG), im-
paired glucose tolerance (IGT) and impaired glucose regu-
lation (IGR) are among the strongest risk factors for
cardiovascular disease (CVD) and death [1,2]. The preva-
lence of T2D is increasing, and it is estimated that by
2025, 15% of the global population will be affected by
T2D, IFG or IGT [3]. The increase is thought to be due to
population growth, ageing, urbanization, physical inactiv-
ity and obesity [4].
Immigrants from the Middle East and their offspring liv-
ing in Sweden are at particularly high risk of T2D [5,6].
Malmö is a multicultural Swedish city. 30% of its residents
were born abroad and the largest immigrant group con-
sists of individuals born in Iraq, who collectively comprise
almost 9,000 of Malmö’s nearly 300,000 inhabitants. In
2010, a pilot survey of almost 200 residents of Rosengård
in Malmö who were born in Iraq or Sweden revealed a
very high prevalence of T2D (20%), independent of coun-
try of birth, perhaps as a result of the study having been
conducted in a socioeconomically vulnerable area [7].
Since January 2011, the MEDIM (the impact of Migration
and Ethnicity on Diabetes In Malmö) project has continu-
ously recruited residents with Iraqi and Swedish back-
grounds aged 30 to 75 years from the whole of Malmö.
Preliminary results obtained by June 2012 show that the
prevalence of T2D is twice as high in Iraqi immigrants (n
= 898) compared to Swedish participants (n = 757) (12.4%
vs. 5.9%, p < 0.001), and that risk factors for T2D, such as
family history of diabetes (52%), physical inactivity (64%)
and obesity (38%), cluster in Iraqi subjects (manuscript
submitted November 2012).
A previous study indicated that patients with T2D
from the Middle East have a different form of T2D, with
earlier onset and stronger family history function [8].
Furthermore, the same study indicated that immigrants
from the Middle East have a more rapid decline in pan-
creatic beta-cell function compared to Swedish diabetic
patients [8]. It is known that physical exercise enhance
beta-cell function in people with diabetes [9] and also in
people at high risk of diabetes or prediabetes [10]. How-
ever, little is known about how increased physical activ-
ity and improved lifestyle habits affect beta-cell function
and/or insulin sensitivity in immigrants from Iraq.
These previous findings indicate that a large proportion
of the Iraqi population is at risk of developing T2D within
the next years. The high prevalence rates of family history
of diabetes, obesity and sedentary lifestyle raise the need
for a lifestyle intervention targeting individuals at risk of
T2D. It is well established that diet- and physical activity-
based lifestyle interventions are effective in preventing or
delaying the onset of T2D in the short term [11,12] and in
the long term [13-16]. However, there are currently no
routines or programs to assist health care providers inimproving lifestyle in individuals at risk of T2D who come
from the Middle East and have a different cultural and so-
cioeconomic background.
Recent studies highlight several obstacles and issues that
need to be addressed in order to achieve successful life-
style change in immigrants from the Middle East. Gender-
specific groups must be offered [17]; physical activity
sessions should be adapted to the preferences of the par-
ticipants [18]; successful intervention models should be
provided by a multidisciplinary team [18]; and the inter-
vention models should mediate behavioral change and
self-empowerment [18]. Therefore, there is a need for a
culturally adapted lifestyle intervention targeted to Iraqi
immigrants that might differ from conventional lifestyle
interventions.
In addition to the challenge of designing a culturally
adapted lifestyle intervention, a further challenge re-
mains in the implementation of the lifestyle interven-
tion in community and primary care settings. Every
intervention costs resources, but resources are always
scarce and informed decision-making is required before
implementation of a program at the mass population
level. Cost-effectiveness analysis can ensure that limited
resources are allocated as efficiently as possible, so that
decision makers can take informed decisions based on
the benefits outweighing the costs [19]. Although active
screening for T2D combined with subsequent lifestyle
intervention is cost-effective [20] compared to the “wait
and see” or “do nothing” approach that currently pre-
vails, no study has emphasized the cost-effectiveness of
culturally adapted lifestyle interventions for high-risk
immigrants from Iraq.
Aim/purpose
Immigrants to Sweden from Iraq are at high risk of devel-
oping T2D, but little is known about factors preventing
the development of T2D in this group. The aims of the
study are to:
(1) Develop a culturally and primary health care-
adapted lifestyle intervention program focusing on
increased levels of physical activity and healthier
eating habits.
(2) Study if the program has an effect on glucose
metabolism (measured as fasting glucose level) and
whether the change in fasting glucose is depending
on insulin sensitivity index (ISI), insulin secretion
(measured as oral disposition index (DIo)) and/or
family history of diabetes.
(3) Explore factors that can predict beneficial and
non-beneficial responses to the lifestyle intervention,
such as baseline physical activity, motivational level,
attitudes towards lifestyle change and adherence to
intervention components.
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The study is a 6-month randomized controlled lifestyle
behavior intervention trial, where intervention and con-
trol groups are followed at 3 and 6 months. Written in-
formed consent will be obtained before randomization.




Participants are recruited from the MEDIM baseline
study that by December 2012 had included 1398 men
and women aged 30 to 75 years born in Iraq, and in
whom a glucose tolerance test was performed and
sociodemography and lifestyle was characterized. In total
40% of the participants are estimated to be at risk of dia-
betes either by having prediabetes (IFG, IGT or IGR) or
by their constellation of risk factors according to
FINDRISC scores [21] resulting in a moderate (17%) to
high risk (33%) to develop diabetes within the next dec-
ade. Thus we will have an eligible population of
1398*0.40 = 560 individuals, of whom 60% or 336 are es-
timated to finally agree to participate in the study. The
participation rate is based on experiences from an inter-
vention study of Arabic women, which had a participa-
tion rate of 62% [17]. In the baseline study 315 Iraqi
individuals had a moderate risk (i.e. an estimated 10 year
incidence rate of diabetes of 17%) [21] and 275 individ-
uals had a high risk (i.e. an estimated 10 year incidence
rate of diabetes of 33%) [21]. Based on a mean time of
two years from baseline to the start of the study, we esti-
mate that 26 individuals may have developed diabetes
during this period. They will consequently be excluded
from the study. Based on a drop-out rate of about 16%,
we estimate that of the 310 individuals that initially par-
ticipated 260 will complete the study (130 per group).
Inclusion criteria were being born in Iraq, age 30 to
75 years and high risk of diabetes as measured by
A. IFG, IGT or IGR identified by an oral glucose
tolerance, plasma glucose (glc) at fasting (f-glc) and
at 2 hours (2-h glc) during glucose tolerance test:
 IFG: f-glc 6.1-6.9 mmol/L (110.125 mg/dL) and
2-h glc <7.8 mmol/L (<140 mg/dL)
 IGT: f-glc < 6.1 mmol/L (<110 mg/dL) and 2-h glc
7.8-11.0 mmol/L (140.199 mg/dL)
 IGR: f-glc . 6.9 mmol/L (.125 mg/dL) and 2-h glc
7.8-11.0 mmol/L (140.199 mg/dL)B. or by Finish diabetes risc score (FINDRISC) with
over 10% risk of diabetes in 10 years.
Exclusion criteria were diabetes, current pregnancy,
mental incapability and/or cognitive impairment, current
CVD or history of CVD events. CVD includes stroke,
angina or myocardial infarction (MI), percutaneous
transluminal coronary angioplasty (PTCA), congestive
heart failure (CHF), coronary artery bypass graft surgery
(CABG), transient ischemic attack (TIA) and peripheral
vascular disease (PVD) or other physical disorders that
prevent physical exercise.
Randomization/blinding
Subjects agreeing to participate will be randomly allocated
to the intervention (n = 155) or control group (n = 155).
Randomization will be stratified by age, gender, predia-
betes and FINDRISC score, with the aim of obtaining an
equal distribution of participants between the two groups.
Spouses will be randomized to the same group, and spouses
not fulfilling the inclusion criteria will be invited to partici-
pate in the study by supporting their husband or wife.
Intervention group
The intervention group will be offered (A) regular group
sessions led by an Arabic-speaking health coach with a
similar ethnic background to the group and (B) free phys-
ical activity sessions. Others showed that the willingness to
enroll in a diabetes prevention program was predicted by
perceived risk of diabetes [22] and before the start of the
study we will hold an education session to provided infor-
mation about how our lifestyle habits influence our health.
Control group
Information will be sent to the primary health care cen-
ter (PHCC) that the participant is at high risk of T2D
and that he/she will participate in the study as control.
The control group will receive “treatment as usual”, i.e.
they will be instructed by nurses in the PHCC to in-
crease their physical activity, to reduce their weight and
to make the same diet changes as those recommended
to the intervention group.
Intervention
The intervention will be based on evidence-based
guidelines for the prevention of T2D [23]. These guide-
lines include a combination of physical activity and diet-
ary intervention and focus on behavior maintenance.
Physical activity and diet counseling will be conducted
in gender-specific groups by a multidisciplinary team.
In order to be easily implemented, the program will be
adapted to present resources in primary health care and
the community. Figure 1 shows a flow chart summary
of the study.
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period of 6 months. Each group will contain 16 individuals
of the same gender (there will be five groups of men and
five groups of women). The sessions target diet, physical
activity and behavioral change with the goal of equipping
the subjects with the necessary knowledge and skills to
gradually achieve permanent behavioral changes. Behav-
ioral change is a model involving motivation, action and
maintenance [24]. It supports changes in diet and physical
activity and goal-setting, and involves action planning with
goals and coping strategies. The intervention group will be
supported in their efforts to reach the following goals,
which are considered to have preventive effects against
diabetes [15,24]: weight reduction of ≥5%, moderate in-
tensity physical activity ≥30 minutes at least 5 days/
week, dietary fat <30% of total energy (E%), saturated
fat <10 E% and fiber ≥15 g/1000 kcal. The participants
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Weight x x x x
Waist circumference x x x x
Buttock circumference x x x x
Clinical
Fasting plasma glucose x x x x
Cholesterol x x x x
Triglycerides x x x x
HDL-C x x x x
LDL-C x x x x
HbA1c x x x x
C-peptide x x x x
s-insulin x x x x
OGTT x x x x
Physical cctivity
IPAQ x x x
ActiGraph x x x x
VO2 max x x x
Dietary
Food record x x x
Physical and mental wellbeing
EQ-5D x x x
Hospital Anxiety and Depression Scale
(HADS)
x x x x
Questionnaire
Sociodemographics x x
Stage of change x x x
Self-determination theory (TSRQ) x x x
Alcohol habits (AUDIT) x x x x
Tobacco habits x x x x
Cost x
Willingness to pay (WTP) x
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sions focusing on individual problems and behavioral
change. In addition, there will be between-visits phone
calls to encourage and motivate the participants to
maintain their new lifestyle habits.
Exercise sessions
Previous studies have shown beneficial effects of aerobic
and resistance training on glucose metabolism in sub-
jects with IGT [25,26]. In this study, physical activity will
be prescribed using physical activity on prescription (in
Swedish “FaR” [27]. The participants will be encouraged
to participate in a physical activity program combining
resistance exercise and endurance training two to three
times a week to increase their possibility of reaching out-
come goals. The resistance exercise training will be
performed with their own body weight, rubber bands
and dumbbells and aims to increase muscle strength and
endurance. The aerobic endurance training will com-
prise self-selected activities, such as aerobic classes,
swimming, soccer, jogging or walking led by certified in-
structors. As far as possible, the endurance classes and
resistance training classes will be supervised by a leader
from Iraq of the same gender as the group. Participation
lists will be filled in by the supervisors of the physical ac-
tivity classes.
Assessment and outcome measures
Trained Swedish- and Arabic-speaking research nurses
will conduct the measurement procedures. Measurement
will be conducted at baseline, in the middle of interven-
tion (3 months) and at the end of intervention (6 months).
Table 1 shows a schedule for the assessments that the par-
ticipants will undergo during the study period.
Sociodemographic measurements
Sociodemographic data will be collected at baseline only
and will include age, education level, household income,
employment status, marital status, years spent in Sweden,
language spoken at home and with friends, complete fam-
ily history of diabetes in first- and second-degree relatives,
current and previous illness and co-morbidities, and
current medications.
Anthropometrical measurements
Height will be measured to the nearest centimetre using a
wall-mounted stadiometer. Weight will be measured to
the nearest kilogram with participants wearing light cloth-
ing, but not shoes, using a calibrated 34–5062 RTC3010
electronic scale (Coline, China). Body mass index (BMI)
will be calculated as weight (kg) divided by height squared
(m2). Waist circumference will be measured twice with a
tape to the nearest 0.1 cm at the midpoint between the
lowest rib margin and the iliac crest. Buttock (hip)circumference will be measured where the protrusion of
the buttocks is greatest.
Biomedical measurement
Participants will be instructed not to eat or drink any-
thing but water or consume tobacco after 10 pm the day
before testing and to bring a record of their current
medications. Blood pressure will be measured in the su-
pine position after five minutes’ rest and with the arm at
heart level. The mean of two measurements, taken one
minute apart, will be used in analyses. Blood samples
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ously during the study. Serum insulin (s-insulin) levels
will be measured by Access© Ultrasensitive Insulin
radioimmunoassay (Beckman Coulter, USA) [28]; serum
cholesterol and triglyceride levels will be measured using
enzymatic methods (Bayer Diagnostics) [29]. Serum
HDL-cholesterol levels will be measured enzymatically
after isolation of LDL and VLDL (Boehringer Mannheim
GmbH, Germany); LDL-cholesterol levels will be esti-
mated using Friedewald’s equation [30]. C-peptide levels
will be measured with a one-step immunometric sand-
wich electrochemiluminescence immunoassay (ECLI)
based on a ruthenium (Ru) derivative (Roche). A stand-
ard 75-g OGTT will be performed and blood samples
will be collected at 0, 30, 60 and 120 min. Blood glucose
(f-glucose) will be measured in venous whole blood im-
mediately after sampling using a photometer (HemoCue
AB, Ängelholm, Sweden) [31]. HbA1c will be estimated
by high-pressure liquid chromatography (HPLC) with a
VARIANT™ TURBO Hemoglobin A1c Kit 2.0 (Bio-Rad).
ISI, corrected insulin response (CIR) and DIo will be cal-
culated from the OGTT results. ISI will be calculated as
follows:
ISI ¼ 10; 000=√ f−glucose mmol=Lð Þ  s−insulin mIE=Lð Þð Þ
mean OGTT glucose conc: mmol=Lð Þ
mean OGTT insulin conc: mIE=Lð ÞÞ
[32].
CIR provides an estimation of beta-cell function and
will be calculated as follows:
CIR ¼ 100 insulin at 30 min= gluc30 gluc30–3:89ð Þð Þð
[33], where gluc30 is glucose at 30 min and must
be >4.44 mmol/l and >f-glc [34].
DIo provides an estimate of beta-cell function adjusted
for insulin resistance, and is calculated as CIR multiplied
by ISI [35].
Physical activity and cardiorespiratory fitness
We will use two types of physical activity measurement
methods: self-report and objective. The self-administered,
long version of the International Physical activity Question-
naire (IPAQ) will be used to assess self-reported physical ac-
tivity level, as it may provide the most reliable data for the
present study [36]. IPAQ is one of the most used and evalu-
ated questionnaires [36]. However, self-report methods may
be subject to recall bias and may provide different results
compared to objective instruments such as accelerometers
[37]. Therefore, we will also use ActiGraph accelerome-
ters, which are most commonly used in research to pro-
vide an objective measure of duration, intensity and
frequency of physical activity. Physical activity during all
waking hours in a 10-day period will be measured everysecond month with ActiGraph GT3X accelerometers
(Pensacola, Florida, USA). The GT3X accelerometer pro-
vides sufficient storage capacity for the measurement
period, shows high intra- and inter-monitor reliability
[38,39] and may capture a wide range of physical activity
intensities [40,41]. A period of 10 days provides sufficient
information to capture the variation in physical activity
[42].
Cardiorespiratory fitness will be assessed by measuring
maximum aerobic capacity (VO2 max). Subjects will
undergo a 6-minute walking test that provides an indirect
estimate of oxygen uptake [43] and that has been validated
in subjects up to 65 years of age [44]. Performance is esti-
mated by measuring heart rate and walking time at the end
of the test, with adjustment for age, gender and BMI. A pre-
requisite for conducting the test is the ability to walk briskly
and to achieve a heart rate of ≥70% of the age-related max-
imal heart rate.
Dietary measurements
The participants will fill in forms with questions covering
frequency and estimated level of intake of different foods
(such as meat, fish, vegetables, potatoes, rice and cereals
fruit, and different snacks), and how the food was prepared
(cooked, deep fried, fried), to capture total food intake and
habits (breakfast, lunch, dinner, snacks and beverages) dur-
ing the last three days. Since there are no validated food
questionnaires for Arabic foods and food habits, the ques-
tionnaires will be developed in collaboration with nutrition-
ists and Arabic-speaking health coaches with knowledge
about Arabic food habits and culture. The amount of food
will be estimated by the participants by using “Måltidsmått”
from the pharmacies in Sweden (a picture of Måltidsmåttet
is presented at http://www.maltidsmattet.se/), which pro-
vides a measure of the volume of food. Special attention
will be given to food habits during weekends and holidays.
The food questions will be analyzed for nutrient content
using Dietist XP software. The software contains food ta-
bles from the Swedish National Food Administration and
includes almost 1600 food items and 50 nutrients [45].
Tobacco use
Daily smoking increases the risk of 58 different conditions
(including cancer, CVD and pulmonary disorders), which to-
gether account for almost 10% of the total disease burden in
Sweden [46]. Current smoking status (smoker or non-
smoker) will be assessed, together with number of cigarettes
per day for smokers. In addition, participants will be asked
whether they use snuff or smoke water pipes.
Alcohol use
The self-reported version of the Alcohol Use Disorders
Identification Test (AUDIT) from the World Health
Organization (WHO) [47] will be used to assess alcohol
Table 2 Stage of change questionnaire
Response Stage
I am currently not very physically active and I do not
intend to become more physically active during the
next 6 months
Precontemplation
I am currently not very physically active, but I’ve
been thinking about increasing my activity level
during the next 6 months
Contemplation
I am currently not very physically active, but I am
determined to increase my activity level during the
next 6 months
Preparation
I am currently physically active, but I’ve only been so
for the last 6 months
Action
I am currently physically active and I have been so
for longer than 6 months
Maintenance
I was physically active a year ago, but in recent
months I have been less active
Relapse
I do not know
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tor of hazardous and harmful alcohol use, as well as pos-
sible alcohol dependence.
Physical and mental well being
Health-related quality of life
Health-related quality of life will be measured using the
EQ-5D questionnaire [48]. All participants (intervention
and control groups) will complete the Arabic version of
the questionnaire at the start, middle and at the end of
the study.
Hospital anxiety and depression scale
We will use the Hospital Anxiety and Depression Scale
(HADS) [49] to measure the level of anxiety and depres-
sion that each participant is experiencing before imple-
mentation of the lifestyle intervention. Although HADS
was initially developed for hospital patients, it is valid
for primary health care patients [50], as is the Arabic
version as well [51] that will be used in this study.
Motivation and behavioral change
Stage of change questionnaire
Stage of change is a model developed by Prochaska and
colleagues [52]. It identifies five stages that individuals
cycle through as they change specific “health-risk” be-
haviors and the individuals move through a series of
stages in their attempts to accept the desired behavior.
The stages represent a period of time as well as a set of
tasks needed for movement to the next stage. The stage
of change questionnaire will be used to identify each
participants stage in their change towards healthy life-
style habits (Table 2) and special care will be provided to
treat them accordingly [53]. The scientific evidence for
the effect of stage-targeted interventions for individual
factors (e.g. smoking cessation, fat intake reduction) is
strong, but the evidence for complex lifestyle interven-
tions is limited [54].
Self-determination theory
Self-determination theory (SDT) is a general theory of
human motivation that aims to explain individuals’ goal-
directed behavior. It explains the extent to which behav-
iors are autonomous (i.e. originate from the self ) and
the extent to which they are controlled by societal pres-
sure and intrapsychic or interpersonal forces [55]. There
is consistent evidence of the value of using SDT to
understand physical activity behavior [56]. For the
current study, we will use the treatment self-regulation
questionnaire (TSRQ), which was designed to assess the
different forms of motivation within SDT to determine
participants’ motivation to adopt healthy lifestyle habits.
The TSRQ has been validated for physical activity and
healthy eating habits [57].Costs
Direct medical costs, direct non-medical costs and indir-
ect costs will be calculated for both the intervention and
control groups. Direct medical costs represent expendi-
tures for medical services and products and are usually
paid for by the health systems. These costs include the
cost of hospitalization, outpatient care, laboratory tests
and medications. Direct non-medical costs include time
costs of participation in the exercise program, shopping,
food preparation and cooking, and costs of exercise
equipment, special foods and transportation. Indirect
costs are productivity loss costs due to diseases.
Costs will be further divided into those borne by the
program and those incurred by the study participants.
Program costs include training costs and costs associ-
ated with setting up and performing the intervention.
They also include resources required for meetings, staff
preparation, meeting time and materials for the partici-
pants. Overhead and administrative costs will also be
calculated according to recommended methods. Inter-
vention providers (health coaches, nutritionists, physio-
therapists, nurses, medical doctors, etc.) will be
interviewed to determine the time they spent on each
participant and the cost will calculated from their salary
chart sheet. For cost calculation, we will use previously
developed and validated questionnaires of the Diabetes
Prevention Program (DPP) [13]. Each participant will be
asked about the specific costs of their transport to and
from the health care center, time costs and informal care
costs (costs incurred by accompanying persons). Each
participant will be asked about their sickness leave in the
past two months. Participants will report their general
sickness absence in general and also sickness absence
due to physical exercise-related injuries. Lost days of
productivity will be converted into costs by the human
capital method to get the indirect cost.
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Cost-effectiveness analysis will be performed from pa-
tient, health care and societal perspectives. In the soci-
etal perspective, all costs are included irrespective of
who is burdened by them, while the health care perspec-
tive is only concerned with costs burdening the health
care sector. The patient perspective focuses on the costs
that the patients have to bear to change their lifestyle
habits through the intervention. The societal perspective
is generally preferred, although a health care perspective
supplies additional (affordability) information and can
strengthen conclusions based on the societal perspective.
The results will be presented in terms of incremental
cost-effectiveness ratios (ICERs), which show the change
in costs for an incremental benefit [19]. To determine
the cost-effectiveness of the intervention, ICERs will be
calculated for all statistically significant outcomes. In
cost utility analysis, utility values will be calculated using
the EQ-5D questionnaire which provides the health re-
lated quality of life as quality adjusted life years (QALY).
We will perform economic evaluation in two different
time horizons; short-term (within-trial) and long-term.
Within-trial economic evaluation will only focus on the
trial cost data and the outcomes. For long-term duration,
we will develop a decision analytic model based on the
outcome of the trail. This will be done by extrapolating
the secondary clinical outcomes (BMI, blood pressure,
lipid profile) to predict future disease events such as
CVD, diabetes and diabetes-related complications. Each
disease event will have a future cost and QALY. Future
costs and effects will be discounted by 3% per year, but
we intend to perform sensitivity analyses on other rates
[58]. We will analyze uncertainty by both one-way and
multi-way sensitivity analysis, and also by non-parametric
bootstrapping. We will calculate 95% confidence intervals
for the ICERs.
We will also calculate the willingness to pay (WTP) to
be in the program of the participants by the contingent
valuation method. In this method, participants are dir-
ectly asked what they are willing to pay for a benefit or
service [19]. There are many ways to formulate WTP i.e.
open-ended, closed-ended or biding game type [59]. For
the current study, we will use closed-ended questions
with predetermined maximum WTP options. The mon-
etary value will represent the annual subscription fee for
several commercial gymnasiums in Sweden. Participants
will be asked to give reasons for their willingness and
unwillingness to pay. The methodology will follow that
used in two previously published studies with similar
lifestyle interventions [60,61].
Process evaluation
To assess adherence to the intervention protocol,
attendance at group counseling sessions and exercisesessions will be registered, as will accomplishment of
individual activities (e.g. smart goal sheet, FaR).
Cultural adaptation
Special emphasis will be placed on adapting the interven-
tion to the cultural norms, beliefs and traditions of the par-
ticipants from the beginning to the end of the study period.
In order to achieve successful lifestyle change, gender-
specific education exercise groups will be offered and phys-
ical activity sessions will be adapted to the preferences of
the participants [17,18]. Moreover, the intervention will be
provided by a multidisciplinary team comprising a health
coach, nurses, a physiotherapist and a doctor, and mediates
behavioral change and self-empowerment that has been
shown to improve the response to lifestyle change in ethnic
minority groups [18].
Study materials, including the informed consent form,
participant information, food booklets, and newsletters,
will be translated into Arabic. Questionnaires only avail-
able in English or Swedish will be translated into Arabic
according to WHO guidelines for translating instruments
[62] and will be administered by a health care professional
who can speak both Swedish and Arabic.
Statistical analysis
Sample size and power calculation
Fasting glucose
From the baseline study and earlier intervention studies
on Arabic participants, we estimate a standard deviation
(SD) of fasting glucose of 0.6 [12,63]. Based on earlier
studies, we assume that the true difference between the
intervention and control group means is 0.22 mmol/L
[12,63]. We will be able to reject the null hypothesis that
the population means of the intervention and control
groups are equal with a power of 0.86.
Cost-effectiveness analysis
It is assumed that the point estimates for differences in
mean cost and QALY between the intervention and con-
trol groups will be 1000 SEK and 0.18 QALY, respect-
ively, with differences in the SDs for cost and QALY of
5000 SEK and 0.26 QALY, respectively. The sample size
of 260 (130 per group) provides 0.84 power, assuming
that the WTP is 1.3 million SEK [64,65].
Univariate and multivariate analysis
The trial data will be analyzed on an intention-to-treat
basis. Bivariate and multivariate analyses will assess the
effects of the intervention (compared to controls) on
fasting glucose level, weight, physical activity level and
dietary intakes, with adjustment for age and gender, and
will identify factors that can predict beneficial and non-
beneficial responses to the intervention (e.g. baseline
physical activity, motivation, attitude, adherence to the
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paired Student’s t-tests and linear regression, and cat-
egorical variables with chi square tests and logistic re-
gression with 95% confidence intervals.
Follow up and evaluation of data
The intervention and control groups will be followed
up every 3 months for BMI, fasting glucose, HbA1c,
blood pressure, diet registration, physical activity and
fitness, and with questionnaires. The final evalua-
tion conducted after 6 months will also include an
OGTT.
We will study whether the intervention has a sig-
nificant effect on fasting glucose levels and whether this
effect is depending on ISI, DIo or family history of
diabetes. We will also study factors that may predict
these changes, including intensity and amount of phys-
ical activity (measured with ActiGraph accelerometers
and questionnaires) and behavioral factors such as stage
of change and motivation level (measured with questions
originating from self-determination theory).
Ethical approval
The study protocol and informed consent form (in Arabic)
were approved by the Ethical Review Board of Lund
University, Sweden (approval no. 2011/88). The blood
samples are stored in biobank BD35, the Clinical Research
Centre, Region Skåne, Sweden. Access to the blood
samples for other researchers will be regulated by ethical
approvals.
Discussion
This article presents a detailed description of a cultur-
ally adapted randomized controlled trial of a lifestyle
intervention, whose effectiveness in combating risk fac-
tors for T2D and cost-effectiveness we will investigate
in Iraqi immigrants.
Although several resources for lifestyle change are
today available in primary health care in Sweden, these
programs are not culturally adapted and individuals at
high risk of T2D are consequently not given priority. A
considerable proportion of Sweden’s inhabitants are im-
migrants from the Middle East, who have been identified
as a group at high risk of T2D. Instead of just waiting
for these high-risk individuals to develop T2D, the study
seeks to optimize preventive action in the community
and primary health care and aims to facilitate the adop-
tion of changes in lifestyle in high-risk patients, taking
account of cultural and social barriers. A community-
and primary health care-oriented intervention model
based on a successful evidence-based approach targeting
individuals at high risk of T2D with a different cultural
background will increase the probability of successfulpreventive actions in the community and primary health
care in this high-risk group.
There are some potential challenges that may arise
during this study. One challenge is to motivate Muslim
women to participate in physical exercise as the baseline
study have shown that 70% are physically inactive and
may be reluctant to engage in physical exercise [66]. We
aim to solve this issue by offering gender-specific group
sessions with a health coach of the same gender as the
participants. A limitation could be that the physical ac-
tivity sessions are adapted to the preferences of the par-
ticipants, which may be in conflict with the goals of
achieving physical activity. Therefore, this study empha-
sizes increasing the motivational level of the participants
by working on behavioral change.
The MEDIM intervention study will contribute with an
intervention program that is adapted not only to
evidence-based guidelines but also to Middle Eastern cul-
tural and lifestyle habits, which is crucial for the program
to succeed and reach its goals. The project has a strong
clinical approach, focusing on clinical diabetes prevention
research, and aims to provide a cost-effective method to
decrease diabetes risk in a high-risk population. Increased
knowledge in this novel research area would increase our
understanding of the complex mechanisms that contribute
to the high diabetes risk in Iraqi immigrants. The know-
ledge generated through this study will have important
implications for health-related costs, quality of life and
health equity.
Trial status
This trial will recruit participants from October 2013.
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